| Bioactivity | (R)-Asundexian ((R)-BAY-2433334) is the enantiomer of Asundexian (HY-137431). (R)-Asundexian can be used in studies of cardiovascular disease (especially thrombotic or thromboembolic disease), edema, and ophthalmic disease[1]. | |||||||||
| Name | (R)-Asundexian | |||||||||
| CAS | 2064124-85-0 | |||||||||
| Formula | C26H21ClF4N6O4 | |||||||||
| Molar Mass | 592.93 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Jimenez Nunez Eloisa, et al. Preparation of substituted oxopyridine derivatives for the treatment and/or prophylaxis of diseases. Patent WO2017005725A1. |
(R)-Asundexian
CAS: 2064124-85-0 F: C26H21ClF4N6O4 W: 592.93
(R)-Asundexian ((R)-BAY-2433334) is the enantiomer of Asundexian (HY-137431). (R)-Asundexian can be used in studies of c
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.